FINAL EFFICACY AND SAFETY RESULTS FROM AVAglio, A PHASE III TRIAL OF BEVACIZUMAB (BEV) PLUS TEMOZOLOMIDE (TMZ) ANDRADIOTHERAPY (RT) IN NEWLY DIAGNOSED GLIOBLASTOMA

被引：0

作者：

Chinot, Olivier L. ^{[1
]}

Wick, Wolfgang ^{[2
]}

Mason, Warren ^{[3
]}

Henriksson, Roger ^{[4
,5
]}

Saran, Frank ^{[6
]}

Nishikawa, Ryo ^{[7
]}

Carpentier, Antoine F. ^{[8
]}

Khe Hoang-Xuan ^{[9
]}

Kavan, Petr ^{[10
]}

Cernea, Dana ^{[11
]}

Brandes, Alba A. ^{[12
]}

Hilton, Magalie ^{[13
]}

Kerloeguen, Yannick ^{[13
]}

Guijarro, Abajo ^{[13
]}

Cloughsey, Timothy ^{[14
]}

机构：

[1] Aix Marseille Univ, CHU Timone, AP HM, Marseille, France

[2] Univ Med Ctr, Heidelberg, Germany

[3] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada

[4] Reg Canc Ctr Stockholm, Stockholm, Sweden

[5] Umea Univ, Stockholm, Sweden

[6] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England

[7] Saitama Med Univ, Int Med Ctr, Saitama, Japan

[8] Hop Avicenne, Assistance Publ Hop Paris, F-93009 Bobigny, France

[9] Univ Paris 06, Grp Hosp Pitie Salpetriere, APHP, IHU,CRICM, Paris, France

[10] McGill Univ, Montreal, PQ, Canada

[11] Oncol Inst Ion Chiricuta, Cluj Napoca, Romania

[12] Azienda USL Bellaria Maggiore Hosp, Bologna, Italy

[13] L Hoffmann La Roche Ltd, Basel, Switzerland

[14] Univ Calif Los Angeles, Los Angeles, CA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：105 / 106

页数：2